SB 1553

  • Illinois Senate Bill
  • 104th Regular Session
  • Introduced in Senate
  • Senate
  • House
  • Governor

Xylazine-Sched Iii-Penalties

Abstract

Amends the Illinois Controlled Substances Act. Schedules xylazine as a Schedule III controlled substance. Provides for penalties for the knowing manufacture or delivery, or possession with intent to manufacture or deliver xylazine. Provides that, notwithstanding the scheduling of xylazine as a Schedule III controlled substance, the prohibition on delivery or possession with intent to deliver xylazine does not apply to licensed veterinarians who lawfully prescribe, dispense, administer, acquire, or use any controlled substance, including xylazine, while acting in the course of their professional practice, in good faith, and in accordance with generally accepted medical standards.

Bill Sponsors (1)

Votes


No votes to display

Actions


Apr 11, 2025

Senate

Rule 3-9(a) / Re-referred to Assignments

Apr 04, 2025

Senate

Rule 2-10 Committee Deadline Established As April 11, 2025

Mar 21, 2025

Senate

Rule 2-10 Committee Deadline Established As April 4, 2025

Feb 19, 2025

Senate

To Criminal Law Clear Compliance

Feb 11, 2025

Senate

Assigned to Criminal Law

Feb 04, 2025

Senate

Filed with Secretary by Sen. Patrick J. Joyce

Senate

Referred to Assignments

Senate

First Reading

Bill Text

Bill Text Versions Format
Introduced HTML PDF

Related Documents

Document Format
No related documents.

Sources

Data on Open States is updated periodically throughout the day from the official website of the Illinois General Assembly.

If you notice any inconsistencies with these official sources, feel free to file an issue.